Notice of Intent to Sole Source University of Maryland Medical Center
Key Takeaways
- Set-aside for No Set Aside businesses
- Work to be performed in BETHESDA, MD
- Industry: Research and Development in Biotechnology (except Nanobiotechnology)
Contract Details
- Notice ID
- 26-007059
- Opportunity Type
- Special Notice
- Sub-Agency
- NATIONAL INSTITUTES OF HEALTH
- Office
- NATIONAL INSTITUTES OF HEALTH - CC
- Posted Date
- Tuesday, July 21, 2026
- Response Deadline
- Tuesday, July 28, 2026
- PSC Code
- 6515
- Set-Aside
- No Set Aside
- Place of Performance
- BETHESDA, MD, 20892
- Status
- Active
Description
The National Institutes of Health (NIH) Clinical Center (CC) seeks a contract with University of Maryland Medical Center at Baltimore (UMB) to provide the patient population to develop a biorepository of patients suspected of or diagnosed with pulmonary hypertension (PH). The objective is to collect blood samples, demographics, clinical assessments, and outcome data in enrolled subjects. These samples will allow us to do translational research across all the World Symposium on PH groups. Product Service Code: 5417 Scientific Research and Development Services NAICS Code: 541714 Research and Development in Biotechnology Place of Performance: Bethesda, MD 20892 USA POTS: 26-007059 Description: This is a notice of intent, not a request for a quotation. A solicitation document will not be issue
Why This Opportunity Matters
HEALTH AND HUMAN SERVICES, DEPARTMENT OF is seeking responses for research and development in biotechnology (except nanobiotechnology) with a set-aside for No Set Aside businesses in BETHESDA, MD. This set-aside designation means eligible businesses face reduced competition from larger firms.
Similar Opportunities
Browse Related
Looking for more opportunities?
Browse our full directory of government contracts
